SCHEMBL7272896

SCHEMBL7272896

CCCCc1nn(C)c2c1C(c1cccc([N+](=O)[O-])c1)C(C(=O)OC)=C(C)N2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.59
MEN1 O00255 2/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2C9 P11712 2/20 0.59
CYP2C19 P33261 2/20 0.59
KMT2A Q03164 2/20 0.59
MAPT P10636 2/20 0.59
LMNA P02545 1/20 0.59
POLB P06746 1/20 0.59
MAPK1 P28482 1/20 0.59
GPR55 Q9Y2T6 1/20 0.59
CYP2D6 P10635 1/20 0.59
TSHR P16473 1/20 0.59
NFKB1 P19838 1/20 0.59
THPO P40225 1/20 0.59
NR3C2 P08235 1/20 0.54
CACNA1F O60840 8/20 0.53
CACNA1D Q01668 8/20 0.53
CACNA1S Q13698 8/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10573652 0.97 HIF1A (0.58) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7271774 0.95 CYP1A2 (0.61) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7282442 0.93 CACNA1C (0.60) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL11009628 0.92 MEN1 (0.59) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL11004137 0.92 MAPT (0.55) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL10788929 0.91 CACNA1F (0.49) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL10788917 0.91 CACNA1F (0.49) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL11013043 0.89 HIF1A (0.55) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7272702 0.87 MEN1 (0.58) HIF1AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL10574651 0.87 MAPT (0.57) HIF1AMEN1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0355234-A1 Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1990-02-28 EP claimed
US-4873334-A HYPOTENSIVE AGENTS, CORONARY VASODILATORS SHIONOGI & CO., LTD. (JP) 1989-10-10 US claimed
EP-0107619-B1 DIHYDROPYRAZOLO(3,4-B)PYRIDINE DERIVATIVES AND PRODUCTION THEREOF SHIONOGI & CO., LTD. (JP) 1987-07-29 EP claimed
EP-0114273-B1 NEW PHARMACOLOGICALLY ACTIVE PYRAZOLOPYRIDINES GRUPPO LEPETIT S.p.A. (IT) 1991-11-06 EP disclosed
US-4954508-A HYPOTENSIVE GRUPPO LEPETIT S.P.A. (IT) 1990-09-04 US disclosed
EP-0355234-A1 Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1990-02-28 EP disclosed
US-4873334-A HYPOTENSIVE AGENTS, CORONARY VASODILATORS SHIONOGI & CO., LTD. (JP) 1989-10-10 US disclosed
EP-0107619-B1 DIHYDROPYRAZOLO(3,4-B)PYRIDINE DERIVATIVES AND PRODUCTION THEREOF SHIONOGI & CO., LTD. (JP) 1987-07-29 EP disclosed
EP-0107619-A1 Dihydropyrazolo(3,4-b)pyridine derivatives and production thereof SHIONOGI & CO., LTD. (JP) 1984-05-02 EP disclosed